9th Jun 2021 14:33
Arecor Therapeutics PLC - Saffron Walden, England-based biopharmaceuticals - Three directors buy 45,503 shares in total at 242.5 pence and 242.7p, worth GBP110,395, on Tuesday. Non-Executive Chair Andrew Richards buys 12,500 shares and now has 217,168, a 0.8% stake. Non-Executive Director Christine Soden also buys 12,500 shares, and Non-Executive Director Jeremy Morgan buys 20,503, both their only holdings. Arecor debuted on AIM last week at an initial public offering price of 226p.
Current stock price: 242.50p, up 7.3% on IPO price
By Tom Waite; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Arecor Therape